The global non-vascular stents market is on track for substantial expansion, with projections indicating a market value of USD 1,408.7 million in 2025, soaring to USD 2,338.8 million by 2035.

Gastrointestinal Stents Market. The global gastrointestinal stents market is experiencing robust growth, with the latest industry analysis projecting it to reach USD 815.34 millio ...

Penn undergraduates won $10,000 in the 2025 Y-Prize competition with their proposal for an adjustable bile duct technology that maintains bile flow without the need for additional surgeries.

Global Endoscopic Retrograde Cholangiopancreatography Market is valued at approximately USD $$ billion in 2022 and is anticipated to grow with a healthy growth rate of more than $$% over the forecast ...

technological advancements associated with biliary stents and surge in demand for minimally invasive procedures have spurred the growth. On the other hand, several complications and high costs ...

Objectives: To assess the effects of adjunctive angioplasty or stenting on a background treatment of anticoagulation and thrombolysis, compared with BMT, sham procedure, thrombolysis, or any ...

Biliary tract cancers (BTCs) are rare malignancies arising from the bile ducts. The incidence of BTCs and the associated mortality is rising, risk factors are largely unknown, and early dignosis is ...

Eight patients underwent the biliary access procedure and had clearance of stones and strictures after one to 10 interventional sessions. There was no major morbidity associated with treatment.

Expert Rev Gastroenterol Hepatol. 2012;6(1):105-114. When double-stent placement (duodenal and biliary) is considered, biliary stent placement can be performed either preceding or following ...

Dr Adam Saltman, NAMSA’s Chief Medical Officer, added, “The CGUARDIANS II study is a well-designed pivotal study that will evaluate the safety and effectiveness of the TCAR procedure as performed with ...

“The CGUARDIANS II study is a well-designed pivotal study that will evaluate the safety and effectiveness of the TCAR procedure as performed with the novel CGuard Prime stent platform with an ...

Dr Adam Saltman, NAMSA's Chief Medical Officer, added, "The CGUARDIANS II study is a well-designed pivotal study that will evaluate the safety and effectiveness of the TCAR procedure as performed with ...